Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer

Genomic alterations in metastatic castration-resistant prostate cancer can be identified in plasma circulating tumour DNA. A large cohort analysis shows reliable detection of clinically relevant alterations through targeted cell-free DNA sequencing with a commercial platform, paving the way for liqu...

Full description

Saved in:
Bibliographic Details
Published in:Nature reviews. Urology 2021-05, Vol.18 (5), p.255-256
Main Authors: Ng, Sarah W. S., Wyatt, Alexander W.
Format: Article
Language:English
Subjects:
692/4028/67/1857
692/4028/67/589/466
692/4028/67/69
692/53/2423
Cancer
Circulating Tumor DNA - genetics
DNA
DNA damage
DNA sequencing
Drug therapy
Genetic aspects
Health aspects
Humans
Identification and classification
Male
Medicine
Medicine & Public Health
Metastasis
Neoplastic Cells, Circulating
News & Views
news-and-views
Nucleotide sequencing
Oncology, Experimental
Prostate cancer
Prostatic Neoplasms, Castration-Resistant - genetics
Urology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c473t-81b051c0eea2d4aa524f21f036cc45dc700418e1783e152f253b875d089b8e513
cites cdi_FETCH-LOGICAL-c473t-81b051c0eea2d4aa524f21f036cc45dc700418e1783e152f253b875d089b8e513
container_end_page 256
container_issue 5
container_start_page 255
container_title Nature reviews. Urology
container_volume 18
creator Ng, Sarah W. S.
Wyatt, Alexander W.
description Genomic alterations in metastatic castration-resistant prostate cancer can be identified in plasma circulating tumour DNA. A large cohort analysis shows reliable detection of clinically relevant alterations through targeted cell-free DNA sequencing with a commercial platform, paving the way for liquid biopsy technology to be integrated into routine clinical practice.
doi_str_mv 10.1038/s41585-021-00455-3
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2503447929</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A661111650</galeid><sourcerecordid>A661111650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-81b051c0eea2d4aa524f21f036cc45dc700418e1783e152f253b875d089b8e513</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhi0EomXhD3BAlpAQlxR_xzku5VOq4AJny-uMd10lTrGTQ_89E7a0FCGcg0czz7zJOxlCnnN2xpm0b6ri2uqGCd4wprRu5ANyylvdNcoK9vA25uKEPKn1kjFjVGsekxMpWyW4tafk8HZJQ5_ynoYpx9RDDkBTpiGVsAx-XivzMk5Loe--bKmv1V9XGqdCR5h9nZEINGBQMJpyU6AmzOaZXpVpLQNWUbM8JY-iHyo8u7k35PuH99_OPzUXXz9-Pt9eNEG1cm4s3zHNAwPwolfea6Gi4JFJE4LSfWjRKbfAWyuBaxGFljvb6p7ZbmdBc7khr4-6-P4fC9TZjakGGAafYVqqE5pJpdpOdIi-_Au9RJ8Zvw4pITqjrDZ31N4P4FKOE3oNq6jbGsPxGJTckLN_UPj0MCYcLcSE-XsNr_5oOIAf5kOdhmWdYr0PiiMYcKC1QHRXJY2-XDvO3LoH7rgHDvfA_doDJ7HpxY21ZTdCf9vy-8cjII9AxVLeQ7nz_h_Zn7Cku2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2522964856</pqid></control><display><type>article</type><title>Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer</title><source>Alma/SFX Local Collection</source><creator>Ng, Sarah W. S. ; Wyatt, Alexander W.</creator><creatorcontrib>Ng, Sarah W. S. ; Wyatt, Alexander W.</creatorcontrib><description>Genomic alterations in metastatic castration-resistant prostate cancer can be identified in plasma circulating tumour DNA. A large cohort analysis shows reliable detection of clinically relevant alterations through targeted cell-free DNA sequencing with a commercial platform, paving the way for liquid biopsy technology to be integrated into routine clinical practice.</description><identifier>ISSN: 1759-4812</identifier><identifier>EISSN: 1759-4820</identifier><identifier>DOI: 10.1038/s41585-021-00455-3</identifier><identifier>PMID: 33742188</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/4028/67/1857 ; 692/4028/67/589/466 ; 692/4028/67/69 ; 692/53/2423 ; Cancer ; Circulating Tumor DNA - genetics ; DNA ; DNA damage ; DNA sequencing ; Drug therapy ; Genetic aspects ; Health aspects ; Humans ; Identification and classification ; Male ; Medicine ; Medicine &amp; Public Health ; Metastasis ; Neoplastic Cells, Circulating ; News &amp; Views ; news-and-views ; Nucleotide sequencing ; Oncology, Experimental ; Prostate cancer ; Prostatic Neoplasms, Castration-Resistant - genetics ; Urology</subject><ispartof>Nature reviews. Urology, 2021-05, Vol.18 (5), p.255-256</ispartof><rights>Springer Nature Limited 2021</rights><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>Springer Nature Limited 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-81b051c0eea2d4aa524f21f036cc45dc700418e1783e152f253b875d089b8e513</citedby><cites>FETCH-LOGICAL-c473t-81b051c0eea2d4aa524f21f036cc45dc700418e1783e152f253b875d089b8e513</cites><orcidid>0000-0003-2399-0329</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33742188$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ng, Sarah W. S.</creatorcontrib><creatorcontrib>Wyatt, Alexander W.</creatorcontrib><title>Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer</title><title>Nature reviews. Urology</title><addtitle>Nat Rev Urol</addtitle><addtitle>Nat Rev Urol</addtitle><description>Genomic alterations in metastatic castration-resistant prostate cancer can be identified in plasma circulating tumour DNA. A large cohort analysis shows reliable detection of clinically relevant alterations through targeted cell-free DNA sequencing with a commercial platform, paving the way for liquid biopsy technology to be integrated into routine clinical practice.</description><subject>692/4028/67/1857</subject><subject>692/4028/67/589/466</subject><subject>692/4028/67/69</subject><subject>692/53/2423</subject><subject>Cancer</subject><subject>Circulating Tumor DNA - genetics</subject><subject>DNA</subject><subject>DNA damage</subject><subject>DNA sequencing</subject><subject>Drug therapy</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Identification and classification</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastasis</subject><subject>Neoplastic Cells, Circulating</subject><subject>News &amp; Views</subject><subject>news-and-views</subject><subject>Nucleotide sequencing</subject><subject>Oncology, Experimental</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms, Castration-Resistant - genetics</subject><subject>Urology</subject><issn>1759-4812</issn><issn>1759-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kk1v1DAQhi0EomXhD3BAlpAQlxR_xzku5VOq4AJny-uMd10lTrGTQ_89E7a0FCGcg0czz7zJOxlCnnN2xpm0b6ri2uqGCd4wprRu5ANyylvdNcoK9vA25uKEPKn1kjFjVGsekxMpWyW4tafk8HZJQ5_ynoYpx9RDDkBTpiGVsAx-XivzMk5Loe--bKmv1V9XGqdCR5h9nZEINGBQMJpyU6AmzOaZXpVpLQNWUbM8JY-iHyo8u7k35PuH99_OPzUXXz9-Pt9eNEG1cm4s3zHNAwPwolfea6Gi4JFJE4LSfWjRKbfAWyuBaxGFljvb6p7ZbmdBc7khr4-6-P4fC9TZjakGGAafYVqqE5pJpdpOdIi-_Au9RJ8Zvw4pITqjrDZ31N4P4FKOE3oNq6jbGsPxGJTckLN_UPj0MCYcLcSE-XsNr_5oOIAf5kOdhmWdYr0PiiMYcKC1QHRXJY2-XDvO3LoH7rgHDvfA_doDJ7HpxY21ZTdCf9vy-8cjII9AxVLeQ7nz_h_Zn7Cku2A</recordid><startdate>20210501</startdate><enddate>20210501</enddate><creator>Ng, Sarah W. S.</creator><creator>Wyatt, Alexander W.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2399-0329</orcidid></search><sort><creationdate>20210501</creationdate><title>Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer</title><author>Ng, Sarah W. S. ; Wyatt, Alexander W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-81b051c0eea2d4aa524f21f036cc45dc700418e1783e152f253b875d089b8e513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>692/4028/67/1857</topic><topic>692/4028/67/589/466</topic><topic>692/4028/67/69</topic><topic>692/53/2423</topic><topic>Cancer</topic><topic>Circulating Tumor DNA - genetics</topic><topic>DNA</topic><topic>DNA damage</topic><topic>DNA sequencing</topic><topic>Drug therapy</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Identification and classification</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastasis</topic><topic>Neoplastic Cells, Circulating</topic><topic>News &amp; Views</topic><topic>news-and-views</topic><topic>Nucleotide sequencing</topic><topic>Oncology, Experimental</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms, Castration-Resistant - genetics</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ng, Sarah W. S.</creatorcontrib><creatorcontrib>Wyatt, Alexander W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ng, Sarah W. S.</au><au>Wyatt, Alexander W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer</atitle><jtitle>Nature reviews. Urology</jtitle><stitle>Nat Rev Urol</stitle><addtitle>Nat Rev Urol</addtitle><date>2021-05-01</date><risdate>2021</risdate><volume>18</volume><issue>5</issue><spage>255</spage><epage>256</epage><pages>255-256</pages><issn>1759-4812</issn><eissn>1759-4820</eissn><abstract>Genomic alterations in metastatic castration-resistant prostate cancer can be identified in plasma circulating tumour DNA. A large cohort analysis shows reliable detection of clinically relevant alterations through targeted cell-free DNA sequencing with a commercial platform, paving the way for liquid biopsy technology to be integrated into routine clinical practice.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>33742188</pmid><doi>10.1038/s41585-021-00455-3</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-2399-0329</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1759-4812
ispartof Nature reviews. Urology, 2021-05, Vol.18 (5), p.255-256
issn 1759-4812
1759-4820
language eng
recordid cdi_proquest_miscellaneous_2503447929
source Alma/SFX Local Collection
subjects 692/4028/67/1857
692/4028/67/589/466
692/4028/67/69
692/53/2423
Cancer
Circulating Tumor DNA - genetics
DNA
DNA damage
DNA sequencing
Drug therapy
Genetic aspects
Health aspects
Humans
Identification and classification
Male
Medicine
Medicine & Public Health
Metastasis
Neoplastic Cells, Circulating
News & Views
news-and-views
Nucleotide sequencing
Oncology, Experimental
Prostate cancer
Prostatic Neoplasms, Castration-Resistant - genetics
Urology
title Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T19%3A32%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Building%20confidence%20in%20circulating%20tumour%20DNA%20assays%20for%20metastatic%20castration-resistant%20prostate%20cancer&rft.jtitle=Nature%20reviews.%20Urology&rft.au=Ng,%20Sarah%20W.%20S.&rft.date=2021-05-01&rft.volume=18&rft.issue=5&rft.spage=255&rft.epage=256&rft.pages=255-256&rft.issn=1759-4812&rft.eissn=1759-4820&rft_id=info:doi/10.1038/s41585-021-00455-3&rft_dat=%3Cgale_proqu%3EA661111650%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c473t-81b051c0eea2d4aa524f21f036cc45dc700418e1783e152f253b875d089b8e513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2522964856&rft_id=info:pmid/33742188&rft_galeid=A661111650&rfr_iscdi=true